as a continuous variable), female gender (1.48), Asian (1.25) or African origin (1.29), diabetes (1.27), obesity (1.31), hypothyroidism (1.38), chronic liver (1.24) or kidney disease (1.25), alcohol consumption (1.22), exercise (1.23), the use of antiarrhythmic agents (1.31), calcium channel blockers (1.36) or statins, primarily at high doses (1.38) [411]
These efforts aim to establish novel roles for GLP-1RAs in cancer prevention
PMCID: PMC5986433
The two GLP-1 medications have some similar and some unique side effects
Clinical trials supporting their approval typically lasted 68 to 72 weeks, but extension studies have followed patients for longer periods
However, we identified N-acetyl-L-carnosine, a precursor of carnosine, which showed an increasing trend in the serum (Figure 1G)